A rare case study of a female patient suffering from Kyrle disease (hyperkeratosis follicularis etparafollicularis in cutem penetrans)



Cite item

Full Text

Abstract

The article presents a literature review and case study of a rare form of dermatitis in a female patient aged 61 - Kyrle
disease (hyperkeratosis follicularis et parafollicularis in cutem penetrans). It also provides a detailed description of the
clinical picture and differential diagnostics of the disease. The following typical changes were observed based on the
results of histological examination: epidermic invaginations filled with corneous masses and areas of focal parakeratosis.
Essential improvement in skin process dynamics was achieved against the background of treatment with Acitretin.

References

  1. Kyrle J. Hyperkeratosis follicularis et parafollicularis in cutem penetrans. Arch Dermatol Syphilol 1916; 123: 466-493.
  2. Elder D.E., ed. Lever's histopathology of the Skin. 9. Philadelphia: Lippincott Williams and Wilkins: 2005; 403-408.
  3. Lebwohl M. Acquired Perforating Disorders. Ch. 67 In Fitzpatrick's dermatology in general medicine, 7th edition, McGraw-Hill, New York 2008, P. 564-567.
  4. Shivakumar V, Okade R, Rajkumar V et al. Familial Kyrle's disease: a case report. Int J Dermatol 2007; 46 (7): 770-771.
  5. Viswanathan S, Narurkar SD, Rajpal A et al. Rare presentation of Kyrle's disease in siblings. Indian J Dermatol 2008; 53 (2): 85-87.
  6. Kasiakou SK, Peppas G, Kapaskelis AM et al. Regression of skin lesions of Kyrle's disease with clindamycin: implications for an infectious component in the etiology of the disease. J Infect 2005; 50 (5): 412-416.
  7. Carter VH, Conslantine VS. Kyrle's disease: I. Clinical findings in five cases and review of the literature. Arch Dermatol 1968; 97: 624-632.
  8. Carter VH, Conslantine VS. Kyrle's disease: II. Histological findings of five cases and review of the literature. Arch Dermatol 1968; 97: 633-639.
  9. Udayakumar P, Balasubramanian S, Ramalingam KS et al. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Indian J Dermatol Venereol Leprol 2006; 72 (2): 119-125.
  10. Tomeski KJ, Battaglini JW, Maize JC. Kyrlie's disease and type II hyperlipoproteinemia. Arch dermatol 1980; 116 (2): 227-228.
  11. Калюжная Л.Д., Довгалюк Т.П., Турик Н.В. и др. Болезнь Кирле. Вестн. дерматол. и венерол., 1989; 10; 78-80.
  12. Кусов В.В., Беренбейн Б.А., Молчанов А.В. Болезнь Кирле. Вестн. дерматол. и венерол., 1988; 7; 46-49.
  13. Hood AF, Hardegen GI, Zarate AR et al. Kyrle's disease in patients with chronic renal failure. Arch dermatol 1982; 118; 85-87.
  14. Pajarre R, Alavaikko M. Kyrlie's disease. Acta Derm Venereol 1973; 54: 505-508.
  15. Wolff-Schreiner E.C. Kyrle's disease. Part 3 In Dermatology in general medicine. (Fitzpatrick TB, Eisen AZ, Wolf K (eds.)) New-York McGraw-Hill 1987; 1: 541-545.
  16. Slatkin M. Kyrlie's disease. Arch dermatol 1962; 86: 554.
  17. Мордовцева В.В., Мордовцев В.Н., Кряжева С.С. Наследственные болезни ороговения. В кн.: Клиническая дерматовенерология: в 2 т. Под ред. Ю.К. Скрипкина, Ю.С. Бутова. М.: ГЭОТАР-Медиа, 2009; II: 747-749.
  18. Елькин В.Д., Митрюковский Л.С., Седова Т.Г. Избранная дерматология. Редкие дерматозы и дерматологические синдромы. Изд. 2-е. Пермь, 2004, 91-92.
  19. Saleh HA, Lloyd KM, Fatteh S. Kyrle's disease. Effectively treated with isotretinoin. J Fla Med Assoc 1993; 80 (6): 395-3.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 L'vov A.N., Katunina O.R., Matushevskaya Y.I., Svishchenko S.I., Voytsekhovskaya M.A., LVOV A.N., KATUNINA O.R., MATUSHEVSKAYA Y.I., SVISHCHENKO S.I., VOITSEKHOVSKAYA M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies